Cynvec
New York, US · Delaware LLC
Founders & leadership
DO
Daniel O. WildsExecutive
Board
SB
Steve BlumenthalBoard director
LL
Leonard LitwinBoard director
CD
Charles DoregoBoard director
RI
Robert IvanhoeBoard director
RP
Richard PurcellBoard director
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 1 of 2 rounds · 2015–2017
▶$15MofferedAug 2017 · BiotechnologyRule 506(b)
▶$15MofferedAug 2017 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert IvanhoeDirector
- Charles DoregoDirector
- Carole PittelmanDirector
- Steve BlumenthalDirector
- Offering amount
- $15M
- Minimum investment
- $250K
- Proceeds to insiders
- $200K
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedDec 2015 · 3 investors · BiotechnologyRule 506(b)
▶$1.9MraisedDec 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PurcellDirector
- Steve BlumenthalDirector
- Leonard LitwinDirector
- Daniel O. WildsExecutive Officer
- Charles DoregoDirector
- Robert IvanhoeDirector
- Offering amount
- $10M
- Amount sold
- $1.9M
- Minimum investment
- $125K
- Sales commissions
- $584.5K
- Proceeds to insiders
- $180K
- Placement agents
- Daniel Salvatore D'Agostino
- First sale
- Oct 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Cynvec raised?
- Cynvec has disclosed $1.9M raised across 1 of its 2 known rounds.
- Where is Cynvec headquartered?
- Cynvec is headquartered in New York, US.